Wenna Duan1, Parshant Sehrawat1, Tony D Zhou2, James T Becker3,4, Oscar L Lopez4, H Michael Gach2, Weiying Dai1. 1. Department of Computer Science, State University of New Yorkat Binghamton, Binghamton, NY, USA. 2. Departments of Radiation Oncology, Radiology, and Biomedical Engineering, Washington University in St. Louis, Saint Louis, MO, USA. 3. Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA. 4. Department of Psychiatry and Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract
BACKGROUND: Biomarkers for Alzheimer's disease (AD) are crucial for early diagnosis and treatment monitoring once disease modifying therapies become available. OBJECTIVE: This study aims to quantify the forward magnetization transfer rate (kfor) map from brain tissue water to macromolecular protons and use it to identify the brain regions with abnormal kfor in AD and AD progression. METHODS: From the Cardiovascular Health Study (CHS) cognition study, magnetization transfer imaging (MTI) was acquired at baseline from 63 participants, including 20 normal controls (NC), 18 with mild cognitive impairment (MCI), and 25 AD subjects. Of those, 53 participants completed a follow-up MRI scan and were divided into four groups: 15 stable NC, 12 NC-to-MCI, 12 stable MCI, and 14 MCI/AD-to-AD subjects. kfor maps were compared across NC, MCI, and AD groups at baseline for the cross-sectional study and across four longitudinal groups for the longitudinal study. RESULTS: We found a lower kfor in the frontal gray matter (GM), parietal GM, frontal corona radiata (CR) white matter (WM) tracts, frontal and parietal superior longitudinal fasciculus (SLF) WM tracts in AD relative to both NC and MCI. Further, we observed progressive decreases of kfor in the frontal GM, parietal GM, frontal and parietal CR WM tracts, and parietal SLF WM tracts in stable MCI. In the parietal GM, parietal CR WM tracts, and parietal SLF WM tracts, we found trend differences between MCI/AD-to-AD and stable NC. CONCLUSION: Forward magnetization transfer rate is a promising biomarker for AD diagnosis and progression.
BACKGROUND: Biomarkers for Alzheimer's disease (AD) are crucial for early diagnosis and treatment monitoring once disease modifying therapies become available. OBJECTIVE: This study aims to quantify the forward magnetization transfer rate (kfor) map from brain tissue water to macromolecular protons and use it to identify the brain regions with abnormal kfor in AD and AD progression. METHODS: From the Cardiovascular Health Study (CHS) cognition study, magnetization transfer imaging (MTI) was acquired at baseline from 63 participants, including 20 normal controls (NC), 18 with mild cognitive impairment (MCI), and 25 AD subjects. Of those, 53 participants completed a follow-up MRI scan and were divided into four groups: 15 stable NC, 12 NC-to-MCI, 12 stable MCI, and 14 MCI/AD-to-AD subjects. kfor maps were compared across NC, MCI, and AD groups at baseline for the cross-sectional study and across four longitudinal groups for the longitudinal study. RESULTS: We found a lower kfor in the frontal gray matter (GM), parietal GM, frontal corona radiata (CR) white matter (WM) tracts, frontal and parietal superior longitudinal fasciculus (SLF) WM tracts in AD relative to both NC and MCI. Further, we observed progressive decreases of kfor in the frontal GM, parietal GM, frontal and parietal CR WM tracts, and parietal SLF WM tracts in stable MCI. In the parietal GM, parietal CR WM tracts, and parietal SLF WM tracts, we found trend differences between MCI/AD-to-AD and stable NC. CONCLUSION: Forward magnetization transfer rate is a promising biomarker for AD diagnosis and progression.
Entities:
Keywords:
Alzheimer’s disease; magnetization transfer imaging; magnetization transfer rate; mild cognitive impairment
Authors: Katharina Brueggen; Martin Dyrba; Arturo Cardenas-Blanco; Anja Schneider; Klaus Fliessbach; Katharina Buerger; Daniel Janowitz; Oliver Peters; Felix Menne; Josef Priller; Eike Spruth; Jens Wiltfang; Ruth Vukovich; Christoph Laske; Martina Buchmann; Michael Wagner; Sandra Röske; Annika Spottke; Janna Rudolph; Coraline D Metzger; Ingo Kilimann; Laura Dobisch; Emrah Düzel; Frank Jessen; Stefan J Teipel Journal: J Neurol Date: 2019-06-21 Impact factor: 4.849
Authors: José Luis Molinuevo; Pablo Ripolles; Marta Simó; Albert Lladó; Jaume Olives; Mircea Balasa; Anna Antonell; Antoni Rodriguez-Fornells; Lorena Rami Journal: Neurobiol Aging Date: 2014-06-06 Impact factor: 4.673
Authors: Oscar L Lopez; William J Jagust; Steven T DeKosky; James T Becker; Annette Fitzpatrick; Corinne Dulberg; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller Journal: Arch Neurol Date: 2003-10
Authors: Weiying Dai; Oscar L Lopez; Owen T Carmichael; James T Becker; Lewis H Kuller; H Michael Gach Journal: Radiology Date: 2009-01-21 Impact factor: 11.105
Authors: Basil H Ridha; Daniel J Tozer; Mark R Symms; Katherine C Stockton; Emma B Lewis; Musib M Siddique; David G MacManus; Martin N Rossor; Nick C Fox; Paul S Tofts Journal: Radiology Date: 2007-09 Impact factor: 11.105
Authors: Chantel D Mayo; Mauricio A Garcia-Barrera; Erin L Mazerolle; Lesley J Ritchie; John D Fisk; Jodie R Gawryluk Journal: Front Aging Neurosci Date: 2019-01-09 Impact factor: 5.750